On the basis of the clinical observation that the cerebrospinal fluid (CSF) of patients with cryptococcal meningitis contains high levels of the chemokine interleukin (IL)-8 but few polymorphonuclear leukocytes (PMNL), the production of IL-8 by cultured brain glial cells after stimulation with two serotypes of cryptococcal capsular polysaccharide glucuronoxylomannan (GXM) was studied, followed by an assessment of the effect of GXM on PMNL migration toward IL-8. GXM serotype A but not D was capable of inducing IL-8 production in human fetal microglial cell but not in astrocyte cultures. When added directly to the PMNL, GXM (both serotypes) potently blocked PMNL migration toward IL-8. The mechanism of GXM's inhibitory effect appeared to involve crossdesensitization. These findings suggest that GXM can induce IL-8 production in the brain but that GXM in the systemic circulation inhibits migration of PMNL toward IL-8.
The encapsulated yeastlike fungus Cryptococcus neoformans CSF and serum of most patients. As early as 1951, Drouhet and Segretain [3] described that cryptococcal polysaccharide is the leading mycologic cause of central nervous system infection in the immunocompromised host. Cell-mediated immunity could inhibit chemotaxis of leukocytes toward FMLP. Moreover, the major polysaccharide component, glucuronoxylomanplays an important role in host defense against this opportunist. However, the pathogenesis of cryptococcosis is still incomnan (GXM), which consists of a a-1,3-linked polymannose backbone with O-acetyl substituents and b-linked monomeric pletely understood [1] .
Recently, Chaka et al. (unpublished data) analyzed cerebrobranches of xylose and glucuronic acid, has been shown to induce the production of proinflammatory cytokines [4] and spinal fluid (CSF) samples from human immunodeficiency virus-positive patients with cryptococcal meningitis and found chemokines [5] by human leukocytes. Therefore, in the present study, two hypotheses were tested: that cryptococcal GXM can high levels of interleukin (IL)-8 (nanogram per milliliter range), much higher than IL-8 detected in parallel serum samples. ILinduce IL-8 production by brain cells but that GXM blocks the migration of PMNL toward IL-8. 8 is a potent chemoattractant for polymorphonuclear leukocytes (PMNL), and in an animal model in which IL-8 was delivered intracerebrally, PMNL rapidly invaded the blood-brain barrier Materials and Methods (BBB) [2] . However, the CSF of patients with cryptococcal meningitis typically shows a paucity of leukocytes, predomiReagents. IL-8, IL-1b, and anti-IL-8 antibodies were provided by R&D Systems (Minneapolis). Anti-goat horseradish pernantly mononuclear cells and virtually no PMNL. Taken tooxidase (HRP) conjugate was obtained from Jackson Immune Regether, these observations suggest that in cryptococcal meningisearch (West Grove, PA). Lipopolysaccharide (LPS) and tis, IL-8 is produced within the brain but that PMNL do not polymyxin B were acquired from Sigma-Aldrich (St. Louis).
cross the BBB in response to IL-8.
Cryptococcal capsular polysaccharide. Purified GXM, ob- In patients with cryptococcal meningitis, high levels of cryptained as previously described [6] contained constituents other than those known to occur in GXM
The Journal of Infectious Diseases 1998;177:260-3 [6] . GXM was dissolved in 50 mg/mL Hanks' balanced salt solu- Glial cell cultures. Human fetal microglia and astrocytes were Bethesda, MD), as described previously [9] with slight modifications. A polyvinylpyrrolidone-free polycarbonate membrane of 3-obtained from brain tissues of 16-to 22-week aborted fetuses, using previously described techniques [7, 8] . Greater than 99% of mm pore size (Poretics Products, Livermore, CA) was used. Materials being assessed for chemoattractive activity (IL-8 and GXM) cells in the microglial cell preparation stained positively with anti-CD68, a marker for human macrophages, and õ1% stained with and medium control (Gey's balanced salt solution; Sigma), were placed in the lower wells of the chamber. PMNL suspension, with antibodies to glial fibrillary acid protein (GFAP, an astrocyte marker; Dako, Carpinteria, CA). Greater than 99% of cells in the or without added GXM (20 min of preincubation), was added to the upper chamber wells. Each potential chemoattractant was astrocyte cultures stained positively with antibodies to GFAP. Cell viability, assessed by trypan dye exclusion, was ú98%.
examined in triplicate. After 45 min of incubation at 37ЊC, the membrane separating both chambers was removed, and nonmigrat-ELISA for IL-8 detection. IL-8 levels in glial cell cultures were quantified by an ELISA. Briefly, purified mouse anti-human IL-8 ing cells were gently scraped from the upper side of the filter. Cells on the lower side of the membrane were stained (Diff-Quick; antibodies were coated overnight at 4ЊC onto 96-well microtiter plates at 1 mg/mL. The wells were blocked and washed with 1%
Baxter, McGaw Park, IL) and examined with light microscopy. Five microscopic fields per well were examined under high power bovine serum albumin (BSA) in PBS for 1 h at 37ЊC, followed by the addition of samples and a series of dilutions of standard (11000), and the average number of PMNL per field that had migrated to the other side of the membrane was determined. IL-8 in triplicate for 2 h at 37ЊC. The wells were then washed with PBS-Tween 20 (0.5%) and incubated with goat anti-human Statistical analysis. Data are expressed as mean { SE of triplicate values from a representative experiment or as mean { SE of IL-8 antibody (2 mg/mL) for 1.5 h, followed by washing and incubation with donkey anti-goat HRP conjugate (1:20,000 in three separate experiments (performed in triplicate). Differences between the means of two groups were analyzed by Student's t PBS) for an additional 1 h at 37ЊC. After intensive washing, substrate buffer of K-blue (ELISA Technology, Lexington, KY) was test (Statview II; Abacus Concepts, Berkeley, CA). used for color development, and the reaction was stopped after 30 min by addition of 1 M H 2 SO 4 and read by 450 nm. The detection limit for this assay was 10 pg/mL IL-8.
Results
Experimental design for chemokine induction. Human microglia or astrocytes were seeded onto 96-well plates (5 1 1.2 ng/mL), while polymyxin B inhibited 10 ng/mL LPS-induced described previously [5, 9] . PMNL migratory activity was assessed by using a 48-well modified Boyden chamber (Neuro Probe, IL-8 production by ú85% (LPS [10 ng/mL]: 106.0 { 10.6 ng/ Effects of (A) glucuronoxylomannan (GXM), serotypes A and D or (B) IL-8 on polymorphonuclear leukocyte (PMNL) migration toward chemoattractants IL-8 (50 ng/mL) and/or GXM (both serotypes, 500 mg/mL). Chemoattractants or medium, as indicated at top of diagram, were added to lower chamber of Boyden chamber chemotaxis device. PMNL, in absence (medium) or presence of (A) GXM A (500 mg/mL), GXM D (500 mg/mL), or (B) IL-8 (50 ng/mL), were added to upper chamber and migration of cells toward lower chamber was quantified after 45 min by counting 5 high-power fields (11000) per triplicate. Data represent mean { SE of (A) three independent experiments or (B) triplicates of representative experiment of 2 independent experiments, using cells from different donors. *P õ .05, vs. respective medium value.
mL; LPS plus polymyxin B: 12.9 { 0.9 ng/mL). For the highest contains few PMNL despite high IL-8 levels prompted the hypotheses that the major cryptococcal capsular polysaccharide GXM dose tested, neither GXM serotype was capable of inducing IL-8 production by astrocytes ( figure 1B) . The failure of astrocytes component GXM is capable of both stimulating glial cells to release IL-8 and blocking migration of PMNL toward IL-8. to respond to GXM was not due to an inability of these glial cells to produce IL-8, since astrocytes stimulated with IL-1b released
The findings that cryptococcal GXM serotype A (but not D) induced IL-8 production by human fetal microglial cells (but appreciable amounts of IL-8 ( figure 1B) .
Chemotaxis. To test the hypothesis that GXM blocks the minot astrocytes) and that both GXM serotypes inhibited PMNL migration toward IL-8 support these two hypotheses. gration of PMNL toward IL-8, it was first determined that PMNL (added to the upper chamber of the chemotaxis device) migrated
To our knowledge, this is the initial description of IL-8 production by microglial cells. Microglia are found in about toward IL-8 (added to the lower chamber) in a dose-dependent manner (data not shown). On the basis of these findings, a concenequal numbers as neurons within the cerebral cortex. Moreover, 4%-13% of the cell processes forming the glia limitans of the tration of 50 ng/mL IL-8 was selected for all subsequent experiments. GXM was then added in different concentrations directly BBB have been shown to be of microglial origin [11] . Thus, it is possible that GXM within the brain parenchyma or subto the PMNL (upper chamber). When GXM was added to the PMNL, it blocked migration (ú65%) toward IL-8 at all concentraarachnoid space elicits IL-8 production by microglia. The concentrations of GXM used in this study to induce IL-8 productions tested (range: 0.1-3 mg/mL; data not shown). No significant difference in the inhibitory activity was found between GXM tion reflect values that have been found in CSF and serum of AIDS patients with cryptococcal meningitis [12] . serotypes A and D at these concentrations. Figure 2A shows the inhibitory effect of GXM (500 mg/mL, both serotypes) on IL-8-Variations in virulence of different cryptococcal isolates are thought to be related to the chemical structure of the polysacinduced migration of PMNL. Inhibition of PMNL migration by GXM was not specific for IL-8, since GXM, added to the PMNL charide capsule [1] . Our results show that different GXM serotypes vary in their ability to induce IL-8 production. Most (upper chamber), could also block migration toward GXM and GXM plus IL-8 ( figure 2A) .
clinically important isolates of C. neoformans var neoformans are of serotype A. Little is known about clinical differences To determine whether the blocking effect of GXM on PMNL migration could be related to a cross-desensitization phenomebetween serotypes A and D, although patients with serotype D tend to have a lower incidence of meningitis and a higher non [10], we tested whether the chemoattractant IL-8 itself would also block PMNL migration. Figure 2B shows that addiincidence of skin lesions. [13] Cryptococcal capsular polysaccharide has been shown to tion of IL-8 directly to the PMNL (upper chamber) blocked migration toward IL-8 or GXM (lower chamber), in a way inhibit PMNL migration toward FMLP and C5a [3, 9] . In the present study, both GXM A and D were found to block similar to that shown with GXM.
PMNL migration toward IL-8, the chemokine found in CSF Discussion of patients with cryptococcal meningitis, thus mimicking the clinical situation more closely. Our study confirmed the The recent clinical observation of Chaka et al. (unpublished data) that the CSF of patients with cryptococcal meningitis observation of others that GXM also has chemoattractant
